Silencing TP53 gene expression in cultured fibroblasts increased production of stromal cell-derived factor 1 (SDF-1, officially known as CXCL12) in these cells and promoted the migration and invasion of leukemic and osteosarcoma cells in vitro (Moskovits et al., 2006). Here, CXCL12 is linked to osteosarcoma.